龙牙楤木总苷对大鼠心肌缺血再灌注相关粘附分子表达的影响
|
摘要
研究背景及目的:
随着社会的发展,冠心病已经成为成年人死亡的重要原因,在经济和工业化发达的国家,它在死亡原因中位居前列。我国的冠心病发病率和死亡率虽然远较这些国家为低,但是在大部分地区,特别是在北方和经济发达地区,都发现冠心病的发病率呈逐年上升趋势。因此防治冠心病成为各国医药学界重要研究课题。
心肌缺血再灌注损伤(Myocardium ischemic reperfusion injury,MIRI)是临床常见的病理现象,是冠心病心肌梗死的病理生理学基础。粘附分子与再灌注损伤有着密切关系,各种粘附分子在心肌细胞的缺血/再灌注损伤作用已经愈来愈受到重视。其中P选择素、CD40/CD40L是近年来研究的热点。
作为世界医药的一个重要组成部分,利用天然植物资源治疗疾病,研制有效的防治冠心病的新药物是目前中医药研究的重要方向。冠心病属中医学“胸痹”、“心痛”范畴。其病机以本虚标实,虚实错杂为主,实则寒凝、气滞、血瘀、痰浊;虚则气血阴阳亏虚,而心气虚则为发病之根本、病机之关键。心气亏虚,无以行血,则血脉瘀滞,气虚血瘀为冠心病最常见病机。本课题针对这一病机,研究具有益气活血功效的龙牙枢木(Aralia elata)对心肌细胞的缺血/再灌注损伤的作用。龙牙楤木其主要有效成分龙牙楤木总苷(aralosides)具有抗炎、抗自由基损伤和抗心肌缺血作用。本研究通过建立心肌缺血再灌注模型,模拟急性心肌IRI,探讨龙牙楤木总苷及普奈洛尔对心肌缺血再灌注过程中粘附分子表达的影响。
方法与结果:
第一部分:观察龙牙楤木总苷对心肌缺血再灌注损伤P选择素表达的影响。方法:龙牙楤木总苷等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注5分钟复制心肌缺血再灌注(MI/R)模型,HE染色观察心肌病理学变化,免疫组化法测量心内膜P选择素的表达。结果表明龙牙楤木组与模型组比较无显著差异。波立维组面密度、积分光密度(IOD)值与模型组比较有统计学显著性差异。
第二部分:观察龙牙楤木总苷对心肌缺血再灌注损伤ICAM-1表达及MDA、GSH-PX的影响。方法:龙牙楤木总苷等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注6h复制MI/R模型,HE染色观察心肌病理学变化,检测血清LDH含量,测定心肌MDA、GSH-PX活性,,ELIsA法测定血清sVCAM-1的表达。结果表明:与模型组比较,龙牙楤木组、波立维组血清LDH含量显著降低(P＜0.05),龙牙楤木组、波立维组SOD活性显著升高(P＜0.05),龙牙楤木组、波立维组与模型组ICAM-1表达没有统计学差异(P＞0.05)。
第三部分:本研究旨在研究龙牙楤木总苷对急性心肌梗死引发的室性心律失常及生存率的改善作用。方法:龙牙楤木总苷等药物预处理,然后冠脉左前降支结扎复制心梗模型,计算心律失常评分、室颤发生率、死亡率、除颤成功率。结果:心律失常评分龙牙楤木组和普萘洛尔组与模型组比较无统计学差异(P＞0.05),合心爽组与模型组比较有显著统计学差异(P＜0.05);室颤发生率龙牙楤木组和普萘洛尔组与模型组比较无统计学差异(P＞0.05),合心爽组与模型组比较有显著统计学差异(P＜0.05);死亡率龙牙楤木组和合心爽组与模型组比较有显著统计学差异(P＜0.05)。除颤成功率龙牙楤木组与模型组比较有显著统计学差异(P＜0.05)。
第四部分:观察普奈洛尔对心肌缺血再灌注损伤CD40L表达的影响。方法:普奈洛尔等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注5分钟复制MI/R模型,HE染色观察心肌病理学变化,免疫组化法半定量测量心内膜CD40L的表达。结果表明普奈洛尔组面密度、积分光密度(IOD)值与模型组比较有统计学显著性差异。
结论:
1、龙牙楤木总苷保护心肌的作用与P选择素、ICAM-1表达无直接关系,其机制可能是通过增加GSH-PX的活力,减少MDA含量,对抗氧自由基对心肌细胞的毒害作用,减轻心肌细胞的损伤而实现的。龙牙楤木总苷的作用机制有待进一步研究。
2、普奈洛尔可有效地减少缺血再灌注过程中心内膜CD40L的表达,提示普奈洛尔可以改善内皮细胞功能及再灌注微血管功能失调,是其药理作用机制的新发现。
3、龙牙楤木总苷大大降低急性心梗大鼠的死亡率,改善大鼠急性心梗出现的恶性心率失常的预后,提高生存率。其作用机理可能与龙牙楤木抗心肌缺血、稳定心肌细胞电生理及升高室颤阈有关。
Back Ground and Objective:
In nowadays,coronary heart disease(CHD) was the important cause of adult's death.It is in the first place of all kinds of dead causes in developed countries of economics and industrialization.The incidence rate and mortality of CHD are lower in our country than those countries,but with the development and changes of the society and economics,the incidence rate of CHD is in rising tendency year by year in most of regions,espicaliy in north and developed regions.So the prevention and cure of cardiovascular disease has been the important researchful subject of medicine in each country.
MIRI are the common clinical pathology phenomenon,the pathophysiology foundation of the myocardial infarction in coronary heart disease.Adhesion molecule has closely related to MIRI.Variety of adhesion molecules have been more and more attetion in myocardial ischemic/reperfusion injury.And CD40 / C D40L P-selectin are the hot research points in recent year.
As a important constitution of world-medicine,it is the main researchful direction of traditional Chinese medicine(TCM) of using wildings to treat disease and developing effective new drugs to prevent and cure chest pain,at present. CHD belongs to the"chest pain"or"heartache"category in TCM.Deficiency in origin and excess in superficiality and simultaneous occurrence of deficiency and excess syndromes is its main pathogenesis.Excess in superficiality are cold retained,qi stagnation,blood stasis and obstruction by phlegm.Deficiency in origin are deficiency of qi,blood,yin and yang.Deficiency of heart-qi is the essence of onset of disease and the key of pathogenesis.Qi can't promot circulation of blood because of deficiency of heart-qi,which leads to blood vessels stasis.Blood stasis due to qi deficiency is the most common pathogenesis of CHD. This subject aims at this pathogenesis,uses the method of supplementing qi and activating blood to treat CHD,observes the effect of Aralosides on myocardium ischemic reperfusion injury.
Aralosides possess the capabilities of anti-inflammatory、anti oxygen free radicals and anti myocardial ischemic.The study was performed by using myocardial I/R model to investigate the effects of Aralosides and Propranolol on expression of adhesion molecules in rats after myocardial ischemia/reperfusion injury.
Methods and Results:
PartⅠ:
To investigate effects of Aralosides to the quantity of P-sel expression on endocardium during myocardial ischemia reperfusion.Methods:A model of myocardial ischemia 45min followed by 5min reperfusion was made by reversibly ligating coronary left descending artery.P-sel were observed.As a result, Aralosides has no significant effect of the quantity of P-sel expression.
PartⅡ:
To investigate the effects of Aralosides on expression of inflammatory molecule ICAM-1 and the activity of Malcic Dialdchyde(MDA) & Glutathione Peroxidase(GSH-PX) in rats after myocardial ischemia/reperfusion(MI/R) injury. Methods:A model of myocardial ischemia 45min followed by 6h reperfusion was made by reversibly ligating coronary left descending artery.30 Wistar rats were divided randomly into 3 groups:Ichemia reperfusion Group,Aralosides Goup, Plavix Group.HE staining was used to observe the pathological changes of myocardial issues.The activity of MDA and GSH-PX was measured,too.ELISA was used to determine ICAM-1 expression in myocardium.Results:In rats treated by Aralosides or Plavix,the lactate dehydrogenase LDH) activity was significantly decreased.Meamwhile,Aralosides and Plavix raised the activity of Malcic Dialdchyde(MDA) & Glutathione Peroxidase(GSH-PX).ICAM-1 expression was detected in myocardium after ischemia 45min followed by 6h reperfusion.In rats treated by Aralosides or Plavix,ICAM-1 expression remained unchanged.
PartⅢ:
To investigate the effects of Aralosides on Mortality of rat model with myocardial infarction Methods.Mcthods:43 Wistar rats were divided randomly into 4 groups:ischemia reperfusion group(n=11),Aralosidcs group(n=10), Propranolol group(n=12),Diltiazem group(n=10).The left anterior coronary descending artcry was ligated for 45 min.ECGs werc recorded incessantly during myocardial ischemia.Thc ECG was analysed and given score in Lambeth regulation.The occurrence rate of repcrfusion arrhythemia(VF) was analyscd.Rcsults:In rats treated by Aralosides,the occurrence rate of repcrfusion arrhythemia(VF) showd no difference.However,mortality was significantly decreased.
PartⅣ:
To investigate effects of Propranolol to the quantity of CD40Lexpression on endocardium during myocardial ischcmia reperfusion.Methods:A model of myocardial ischemia 45min followed by 5min reperfusion was made by reversibly ligating coronary left descending artery.As a result,Propranolol reduced the quantity of CD40L expression significantly.
Conclusion:
1.Aralosides could protect myocardium from inflammatory injury during MI/R. Aralosides has no significant effect of P-sel、ICAM-1.The mechanism is related to the enhancement of antioxidative effect on cells,and the reduction membrane damage caused by free radical and lipid peroxide.
2.Propranolol reduced the quantity of CD40L expression significantly during MI/R.This was a new mechanism of their pharmacologic action and as a proof for them to be applied to ACS.
3.Mortality of rat model with myocardial infarction could significantly decreased in rats treated by Aralosides.The mechanism may be related to that Aralosides could protect myocardium from injury during MI/R.
随着社会的发展,冠心病已经成为成年人死亡的重要原因,在经济和工业化发达的国家,它在死亡原因中位居前列。我国的冠心病发病率和死亡率虽然远较这些国家为低,但是在大部分地区,特别是在北方和经济发达地区,都发现冠心病的发病率呈逐年上升趋势。因此防治冠心病成为各国医药学界重要研究课题。
心肌缺血再灌注损伤(Myocardium ischemic reperfusion injury,MIRI)是临床常见的病理现象,是冠心病心肌梗死的病理生理学基础。粘附分子与再灌注损伤有着密切关系,各种粘附分子在心肌细胞的缺血/再灌注损伤作用已经愈来愈受到重视。其中P选择素、CD40/CD40L是近年来研究的热点。
作为世界医药的一个重要组成部分,利用天然植物资源治疗疾病,研制有效的防治冠心病的新药物是目前中医药研究的重要方向。冠心病属中医学“胸痹”、“心痛”范畴。其病机以本虚标实,虚实错杂为主,实则寒凝、气滞、血瘀、痰浊;虚则气血阴阳亏虚,而心气虚则为发病之根本、病机之关键。心气亏虚,无以行血,则血脉瘀滞,气虚血瘀为冠心病最常见病机。本课题针对这一病机,研究具有益气活血功效的龙牙枢木(Aralia elata)对心肌细胞的缺血/再灌注损伤的作用。龙牙楤木其主要有效成分龙牙楤木总苷(aralosides)具有抗炎、抗自由基损伤和抗心肌缺血作用。本研究通过建立心肌缺血再灌注模型,模拟急性心肌IRI,探讨龙牙楤木总苷及普奈洛尔对心肌缺血再灌注过程中粘附分子表达的影响。
方法与结果:
第一部分:观察龙牙楤木总苷对心肌缺血再灌注损伤P选择素表达的影响。方法:龙牙楤木总苷等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注5分钟复制心肌缺血再灌注(MI/R)模型,HE染色观察心肌病理学变化,免疫组化法测量心内膜P选择素的表达。结果表明龙牙楤木组与模型组比较无显著差异。波立维组面密度、积分光密度(IOD)值与模型组比较有统计学显著性差异。
第二部分:观察龙牙楤木总苷对心肌缺血再灌注损伤ICAM-1表达及MDA、GSH-PX的影响。方法:龙牙楤木总苷等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注6h复制MI/R模型,HE染色观察心肌病理学变化,检测血清LDH含量,测定心肌MDA、GSH-PX活性,,ELIsA法测定血清sVCAM-1的表达。结果表明:与模型组比较,龙牙楤木组、波立维组血清LDH含量显著降低(P＜0.05),龙牙楤木组、波立维组SOD活性显著升高(P＜0.05),龙牙楤木组、波立维组与模型组ICAM-1表达没有统计学差异(P＞0.05)。
第三部分:本研究旨在研究龙牙楤木总苷对急性心肌梗死引发的室性心律失常及生存率的改善作用。方法:龙牙楤木总苷等药物预处理,然后冠脉左前降支结扎复制心梗模型,计算心律失常评分、室颤发生率、死亡率、除颤成功率。结果:心律失常评分龙牙楤木组和普萘洛尔组与模型组比较无统计学差异(P＞0.05),合心爽组与模型组比较有显著统计学差异(P＜0.05);室颤发生率龙牙楤木组和普萘洛尔组与模型组比较无统计学差异(P＞0.05),合心爽组与模型组比较有显著统计学差异(P＜0.05);死亡率龙牙楤木组和合心爽组与模型组比较有显著统计学差异(P＜0.05)。除颤成功率龙牙楤木组与模型组比较有显著统计学差异(P＜0.05)。
第四部分:观察普奈洛尔对心肌缺血再灌注损伤CD40L表达的影响。方法:普奈洛尔等药物预处理,然后可逆性冠脉左前降支结扎缺血45min再灌注5分钟复制MI/R模型,HE染色观察心肌病理学变化,免疫组化法半定量测量心内膜CD40L的表达。结果表明普奈洛尔组面密度、积分光密度(IOD)值与模型组比较有统计学显著性差异。
结论:
1、龙牙楤木总苷保护心肌的作用与P选择素、ICAM-1表达无直接关系,其机制可能是通过增加GSH-PX的活力,减少MDA含量,对抗氧自由基对心肌细胞的毒害作用,减轻心肌细胞的损伤而实现的。龙牙楤木总苷的作用机制有待进一步研究。
2、普奈洛尔可有效地减少缺血再灌注过程中心内膜CD40L的表达,提示普奈洛尔可以改善内皮细胞功能及再灌注微血管功能失调,是其药理作用机制的新发现。
3、龙牙楤木总苷大大降低急性心梗大鼠的死亡率,改善大鼠急性心梗出现的恶性心率失常的预后,提高生存率。其作用机理可能与龙牙楤木抗心肌缺血、稳定心肌细胞电生理及升高室颤阈有关。
Back Ground and Objective:
In nowadays,coronary heart disease(CHD) was the important cause of adult's death.It is in the first place of all kinds of dead causes in developed countries of economics and industrialization.The incidence rate and mortality of CHD are lower in our country than those countries,but with the development and changes of the society and economics,the incidence rate of CHD is in rising tendency year by year in most of regions,espicaliy in north and developed regions.So the prevention and cure of cardiovascular disease has been the important researchful subject of medicine in each country.
MIRI are the common clinical pathology phenomenon,the pathophysiology foundation of the myocardial infarction in coronary heart disease.Adhesion molecule has closely related to MIRI.Variety of adhesion molecules have been more and more attetion in myocardial ischemic/reperfusion injury.And CD40 / C D40L P-selectin are the hot research points in recent year.
As a important constitution of world-medicine,it is the main researchful direction of traditional Chinese medicine(TCM) of using wildings to treat disease and developing effective new drugs to prevent and cure chest pain,at present. CHD belongs to the"chest pain"or"heartache"category in TCM.Deficiency in origin and excess in superficiality and simultaneous occurrence of deficiency and excess syndromes is its main pathogenesis.Excess in superficiality are cold retained,qi stagnation,blood stasis and obstruction by phlegm.Deficiency in origin are deficiency of qi,blood,yin and yang.Deficiency of heart-qi is the essence of onset of disease and the key of pathogenesis.Qi can't promot circulation of blood because of deficiency of heart-qi,which leads to blood vessels stasis.Blood stasis due to qi deficiency is the most common pathogenesis of CHD. This subject aims at this pathogenesis,uses the method of supplementing qi and activating blood to treat CHD,observes the effect of Aralosides on myocardium ischemic reperfusion injury.
Aralosides possess the capabilities of anti-inflammatory、anti oxygen free radicals and anti myocardial ischemic.The study was performed by using myocardial I/R model to investigate the effects of Aralosides and Propranolol on expression of adhesion molecules in rats after myocardial ischemia/reperfusion injury.
Methods and Results:
PartⅠ:
To investigate effects of Aralosides to the quantity of P-sel expression on endocardium during myocardial ischemia reperfusion.Methods:A model of myocardial ischemia 45min followed by 5min reperfusion was made by reversibly ligating coronary left descending artery.P-sel were observed.As a result, Aralosides has no significant effect of the quantity of P-sel expression.
PartⅡ:
To investigate the effects of Aralosides on expression of inflammatory molecule ICAM-1 and the activity of Malcic Dialdchyde(MDA) & Glutathione Peroxidase(GSH-PX) in rats after myocardial ischemia/reperfusion(MI/R) injury. Methods:A model of myocardial ischemia 45min followed by 6h reperfusion was made by reversibly ligating coronary left descending artery.30 Wistar rats were divided randomly into 3 groups:Ichemia reperfusion Group,Aralosides Goup, Plavix Group.HE staining was used to observe the pathological changes of myocardial issues.The activity of MDA and GSH-PX was measured,too.ELISA was used to determine ICAM-1 expression in myocardium.Results:In rats treated by Aralosides or Plavix,the lactate dehydrogenase LDH) activity was significantly decreased.Meamwhile,Aralosides and Plavix raised the activity of Malcic Dialdchyde(MDA) & Glutathione Peroxidase(GSH-PX).ICAM-1 expression was detected in myocardium after ischemia 45min followed by 6h reperfusion.In rats treated by Aralosides or Plavix,ICAM-1 expression remained unchanged.
PartⅢ:
To investigate the effects of Aralosides on Mortality of rat model with myocardial infarction Methods.Mcthods:43 Wistar rats were divided randomly into 4 groups:ischemia reperfusion group(n=11),Aralosidcs group(n=10), Propranolol group(n=12),Diltiazem group(n=10).The left anterior coronary descending artcry was ligated for 45 min.ECGs werc recorded incessantly during myocardial ischemia.Thc ECG was analysed and given score in Lambeth regulation.The occurrence rate of repcrfusion arrhythemia(VF) was analyscd.Rcsults:In rats treated by Aralosides,the occurrence rate of repcrfusion arrhythemia(VF) showd no difference.However,mortality was significantly decreased.
PartⅣ:
To investigate effects of Propranolol to the quantity of CD40Lexpression on endocardium during myocardial ischcmia reperfusion.Methods:A model of myocardial ischemia 45min followed by 5min reperfusion was made by reversibly ligating coronary left descending artery.As a result,Propranolol reduced the quantity of CD40L expression significantly.
Conclusion:
1.Aralosides could protect myocardium from inflammatory injury during MI/R. Aralosides has no significant effect of P-sel、ICAM-1.The mechanism is related to the enhancement of antioxidative effect on cells,and the reduction membrane damage caused by free radical and lipid peroxide.
2.Propranolol reduced the quantity of CD40L expression significantly during MI/R.This was a new mechanism of their pharmacologic action and as a proof for them to be applied to ACS.
3.Mortality of rat model with myocardial infarction could significantly decreased in rats treated by Aralosides.The mechanism may be related to that Aralosides could protect myocardium from injury during MI/R.
引文
[1]王丽君,苏小明,孙戈新.龙牙楤木皂昔抗衰老作用的实验研究[J].中国老年学杂志,2007,27(6):1043-1044
[2]王桂云,张淑芹,董琦.龙牙楤木嫩芽生品对小鼠脑及肝SOD及MDA的影响[J].中国林副特产,2003,(1):10
[3]师海波,孙英莲,刘威,等.龙牙楤木总苷对小鼠B型单胺氧化酶及蛋白质合成的影响[J].中药药理与临床,1999,15(6):20-21
[4]葛敬岩,赵春燕.龙牙楤木皂苷对实验性心力衰竭大鼠心功能的影响[J].吉林大学学报,2005,31(2):243-245
[5]葛敬岩,郭春尧,赵春燕,等.龙牙楤木皂苷对大鼠血流动力学的影响[J].白求恩医科大学学报,2001,27(6):601-602
[6]姜永涛,徐绥绪.龙牙楤木化学组成及药理活性[J].沈阳药学院学报,1990,7(4):290
[7]邓汉武,李元建,沈乃,等.辽东楤木总苷对大鼠实验性心肌缺血的保护作用[J].中国药理学与毒理学杂志,1988,2(1):20
[8]孙桂波,徐惠波,温富春,等。龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用[J]国药理学通报,2006,22(9):1092-1095
[9]Tomatsu M,Ohnishi Kameyama M,Shibamoto N.Aralin,a new cytotoxic protein from Aralia elata,inducing apoptosis in human cancer cells[J].Cancer Lett,2003,199(1):19-25.
[10]Tomatsu M,Mujin T,Shibamoto N,Tashiro F,Ikuta A.Production of aralin,a selective cytotoxic lectin against human transformed cells,in callus culture of Aralia elata.[J]Planta Med.2004,70(5):469-71
[11]吴勃岩,王晶,宋春燕.龙牙楤木总皂苷对荷瘤鼠TNF-α的诱生作用[J].中医药学报,2003,31(6):52-53
[12]吴勃岩,祝司霞,王晶.龙牙楤木总皂苷对荷瘤鼠突变型p53表达的影响[J].中医药学报,2005,33(1):38-39
[13]吴勃岩,郭艳莹,毕克滨,等.龙牙楤木总皂苷对荷瘤鼠IL-2含量及其细胞凋亡的影响[J].中医药信息,2005,22(6):58-59
[14]吴勃岩,张韵娴.龙牙楤木总苷的遗传毒性研究[J].中医药学报,1999,(6):47
[15]吴勃岩,韩玉英.龙牙楤木总苷对HepA小鼠肿瘤组织蛋白的表述及M 吞噬功能的影响[J].哈尔滨医科大学学报,2002,(4):45-46
[16]吴勃岩,文杰,张韵娴。龙牙楤木叶总皂苷抗诱变性研究[J].中医药信息,2000,(4):74
[17]季宇彬,李文举,谷春山,等.复方海藻多糖合剂抗癌作用的试验研究[J]. 中国海洋药物,1994,13(3):20-24
[18]西田圭志.辽东楤木中的皂昔对肝炎的效果[J].国外医学·中医中药分册,1990,12(4):63
[19]Saito S,Ebashi J,Sumita S.Comparison of cytoprotective effects of saponins isolated from leaves of Aralia elata Seem.(Araliaceae)with synthesized bisdesmosides of oleanoic acid and hederagenin on carbon tetrachloride-induced hepatic injury[J].Chem Pharm Bull (Tokyo),1993,41(8):1395-401.
[20]杜施霖,迟宝荣.龙牙楤木皂苷对大鼠酒精性肝病的防治作用[J].吉林大学学报(医学版),2005,31(1):64-67
[21]李凡,田同春,石艳春.龙牙楤木总皂苷抗病毒作用研究[J].中国中药杂志,1994,19(9):562-564
[22]孙晓波,周重楚,刘威,等.龙牙楤木总苷的强壮作用[J].中草药,1991,21(2):78
[23]Chung YS,Choi YH,Lee SJ.Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo[J].Ethnopharmacol.2005,3,101(1-3):49-54.
[24]Suh SJ,Jin UH,Kim KW.Triterpenoid saponin,oleanolic acid 3-0-beta-d-glucopyranosyl(1-->3)-alpha-1-rhamnopyranosyl(1-->2)-al pha-1-arabinopyranoside(OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-kappaB in raw 264.7cells,Arch Biochem Biophys.2007,467(2):227-233
[25]周重楚,师海波,李文亭,等.长白木醇提取物的抗炎作用[J].中草药,1991,22(3):114
[26]高勃,张鹏.楤木总苷的中枢抑制作用[J].第四军医大学学报,1988,9(1):55
[27]江苏新医学院.中药大辞典[M].上海:上海人民出版社,1997,2583.
[28]周重楚,师海波,李文亭,等.龙牙楤木总苷的抗缺氧作用[J].中草药,1991,22(3):114
[29]黄立成,姜平.楤木总苷对缺氧耐力的影响[J].西北药学杂志,1988,3(1):13-16
[30]姜永涛,徐绥绪.龙牙楤木化学组成及药理活性[J].沈阳药学院学报,1990,7(4):290
[31]周重楚,孙晓波,高洪波,等.龙牙楤木总苷对变态反应的影响抗炎作用研究[J].中国药理学与毒理学杂志,1991,5(1):34
[32]Kim,Ok kyung,Antihyperglycemic constituent of Aelata rootbark (2) isolation and action of the constituent[J].Aengyak Hakhoechi,1993,24(3):219
[33]Yoshikawa M,Murakami T,Harada E.Bioactive saponins and glycosides.VII.On the hypoglycemic principles from the root cortex of Aralia elata Seem.:structure related hypoglycemic activity of oleanolic acid oligoglycoside[J].Chem Pharm Bull(Tokyo).1996,44(10):1923-1927
[34]Yoshikawa M,Yoshizumi S,Ueno T.Medicinal foodstuffs.I.Hypoglycemic constituents from a garnish foodstuff "taranome," the young shoot of Aralia elata SEEM.:elatosides G,H,I,J,and K[J].Chem Pharm Bull(Tokyo),1995,43(11):1878-1882.
[1]Derek M,Yellon DS.Myocardial Reperfusion Injury.N Eng J Med,2007,357:1121-1135.
[2]Ferdinandy P,Schulz R,Baxter GF.Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury,preconditioning and postcondition- ing.Phamacol Rev,2007,59:418-458
[3]Scalbert EP,Guardiola-Lemaitre B,Delagrange P.Melatonin and regulation of the cardiovascular system.Therapie,1998,53:459-465.
[4]Zweier JL.Measurement of superoxide-derived free radicals in the reperfused heart:Evidence for a free radical mechanism of reperfusion injury.J Biol Chem,1988,263:1353-1357.
[5]Hearse D J,Humphrey SM,Chain EB.Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart:a study of myocardial enzyme release.Mol Cell Cardiol,1973,5:395-407.
[6]Karlsson J.Introduction to Nutraology and Radical Formation.Human Kinetics Press,1997,1-143
[7]Shinohara R,Mano T,Nagasaka A,et al.Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status.J Endocrinol,2000,164(1):97-192
[8]Zhao ZQ.Oxidative stress-elicited myocardial apoptesis during reperfusien.Curt Opin Pharmacol,2004,4:159-165.
[9]Romson JL.Reduction of the exent of myocardial ischemic injury by neutrophil depletion in the dog.Circulation,1983,67(5):1016-1023
[10]Granger DN.Superoxide radicals infelin inteseinal ischemia.Astroenterology,1981,81(1):22-29
[11]朱妙章,钱学贤.心肌损伤和缺血/再灌注损伤.北京:人民军医出版社,2003.
[12]贾新未.氧化应激与血管内皮素功能异常.国际心血管病杂志,2006,33(2):20-21
[13]袁红洁.氧自由基对血管内皮细胞周期及其凋亡水平的影响.南京医科大学学报,1999,19(5):396-397
[14]戴瑞鸿,李勇,范维琥,等.保护内皮细胞功能在防治心血管疾病中的重要性.国际心血管杂志,2000,2(4):328
[15]Reiter RJ,Tan DX,Qi,et al.Pharmacology and physiology of melatonin in the recduction of oxidative stress in vivo.Biol Sigals Recept,2000,9(3-4):160-171
[16]Anisimov VN,Zavarzain NY.Melatonin increases both life span and tumor incidence in female CBA mice.J Gernontol A Biol Sci Ned Sci,2001,56(7):B311-323
[17]Bushehri N,Jarrell ST,Lieberman S,et al.Oral reduced B-nicotinamide ademne dinucleotide(NADn) affects blood pressure,lipid peroxidation,and lipid profile in hypertensive rats(SHR).Geriatr Nephrol Urol,1998,8(2):95-100
[18]Pamplona R,Portero-Otin M,Ruiz C,et al.Double bond content of phospholipids and lipid peroxidation egatively correlate with maximum longevity in the heart of mammals.Geriatr Nephrol Urol,2000,112(3):169-183
[19]Cifuentes ME,Pagano PJ.Targeting reactive oxygen species in hypertension.Curt Opin Nephrol Hypertens,2006,15:179-186.
[20]Das S,Engelman RM,Maulik N,et al.Angiotensin preconditioning of the heart:evidence for redox signaling.Cell Biochem Biophys,2006,44:103-131.
[21]Halestrap AP,Clarke S J,Khaliulin L The role of mitochoudria in protection of the heart by preconditioning.Biochim Biophys Acta,2007,1767:1007-1031.
[22]Gozal Y,Drenger B.Myocardial ischemic preconditioning decreases postischemie oxygen free radical production.Anesthesiology,2003,98:281-282.
[1]RossR.Atherosclerosisaninflammatory disease[J].NEngl JMed,1999,340:115
[2]梅家俊,陈振发.超微病理学基础临床病理学进展[M].武汉:湖北中医学院,2001:95-97;88
[3]邓耀祖,曲伸.医学分子细胞生物学[M].北京:科学出版社,2002:494
[4]莫简.医用自由基生物学导论[M].北京:人民卫生出版社,1989:93-164
[5]龚非力.医学免疫学[M].北京:科学出版社,2000:269,63
[6]Morishima I,Sone T,Okumura K,etal.Angiographic no-reflow phenomenon:a as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J].J Am Corl Cardiol,2000,36:1202
[7]Kloner RA,Rude RE,Carlson N,etal.Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary occlusion:Which comes first?[J].Circulation,1980,62:945
[8]Moncada S,Higgs A.The L-arginine-nitricoxide pathway[J].New Eng J Med,1993,329:2002
[9]Li C,Browder W,Kao R.Early activation of transcription factor NF-kB during lachemia in perfused rat heart[J].Am J physical,1999,276:H543
[10]李淑慧,李晓辉.三七总皂甙抗炎作用机制的实验研究[J].中草药,2000,31(9):676
[11]汪德清,沈文梅,田亚平,等.黄芪有效成分对氧自由基清除作用的ESR研究[J].生物化学与生物物理进展,1996,23(3):260
[12]刘军,匡培根,李斌,等.丹参对大鼠脑缺血再灌注损伤保护机制的实验研究[J].中国神经免疫学和神经病学杂志,1998,5(2):77-82
[13]钟瑜,张焱,杨国汗.川芎嗪对脑缺血再灌注损伤后细胞间粘附作用的影响[J].中西医结合心脑血管杂志,2003,1(5):257,293
[14]倪军,王军,张三林,等.莪红注射液对大鼠心肌缺血再灌注保护作用的研究[J].中西医结合心脑血管杂志,2003,1(10):586-587
[15]倪军,张三林,卫世强,等.莪红注射液对不稳定心绞痛病人血小板颗粒膜蛋白、C反应蛋白的影响[J].中西医结合心脑血管杂志,2003,1(6):326-327[16]沈强,刘亚敏,张赐安.麝香、冰片对全脑缺血再灌注大鼠脑微血管内皮细胞ICAM-1表达的影响[J].中西医结合心脑血管杂志,2003,1(3):136-137
[1]吴克复.细胞通讯与疾病.科学出版社,2006,p24.
[2]孙忠人,张丽娟,赵宇辉,等.针刺预处理对心肌缺血再灌注损伤大鼠c-fos蛋白的影响.中医药信息,2008,25(4):74-75
[3]孙忠人,王一茗.逆灸对心肌缺血再灌注损伤大鼠HSP70的影响.中华中医药学刊.2008,26(7):1382-1383
[4]贺运河,古继红,陈光贤等.益气活血法对大鼠心肌缺血再灌注损伤保护作用的实验研究.中西医结合心脑血管病杂志,2007,5(8):707-708.
[5]戴小华,韩宁林,周宜轩等.益气活血法对心肌缺血再灌注损伤大鼠肿瘤坏死因子α及丙二醛含量的影响.安徽中医学院学报,2003,22(4):39-41.
[6]陈利平,易军.益心汤对心肌缺血再灌注损伤保护作用的研究.解放军医学杂志2003,28(5):447-448.
[7]杨跃进.通心络、卡维地洛及缬沙坦等药物对兔急性心肌梗死晚期再灌注心肌超微结构的影响.络病与心脑血管疾病相关性治疗研究进展学术研讨会论文集.中华医学会杂志社,2004,12:43.
[8]刘艳,赵丹洋,赵明奇,等.通心络改善缺血心肌供血的NO机制研究.络病与心脑血管疾病相关性治疗研究进展学术研讨会论文集.中华医学会杂志社,2004.12:97.
[9]王晓霞,陈志强,刘丽华.参麦注射液对大鼠心肌缺血再灌注损伤的保护效应及其与热休克蛋白的关系,微循环学杂志,2002,12(4):36-37.
[10]郭莲怡,刘仁光.参麦注射液对兔心肌缺血再灌注内皮功能的影响.临床心血管病杂志,2003,19(9):545-547.
[11]郭莲怡,刘仁光.参附注射液对兔心肌缺血再灌注损伤内皮功能的影响.中国中医急症,2003,12(4):349-350.
[12]郑曙云,徐建国,赵振中.参附注射液对大鼠心肌缺血再灌注损伤的影响.中国中西医结合杂志,2004,24(6):541-548.
[13]申捷,许鹏程.参附注射液对缺血再灌注心肌损伤的保护作用.中国临床医学,2006,13(3):344-346.
[14]陈潮,卢伟花.冠脉通瘀汤对心肌缺血再灌注保护作用的研究.中国中医急症,2008,17(7):899-907
[15]侯泽,康文英,沃兴德等.血府逐瘀汤对乳鼠心肌细胞缺血再灌注损伤的影响.中国药物与临床,2006,6(8):590-593.
[16]马骏,石月萍,赵建宇.温阳通脉方预处理对心肌缺血再灌注大鼠MDA 及SOD的影响.中西医结合心脑血管病杂志,2008,6(6):664-665.
[17]王万铁,徐正祄,林丽娜.川芎嗪对实验性缺血-再灌注损伤心肌能量代谢的干预.中国急救医学,2003,23(3):129-130.
[18]王万铁,许涛,徐正祄.川芎嗪对缺血 再灌注损伤兔心肌线粒体结构及功能的影响.基础医学与临床,2004,24(3):295-298.
[19]徐持华,张卫东.川芎嗪对大鼠缺血再灌注心肌预适应性保护与一氧化氮的关系.中国临床康复,2006;10:74-76.
[20]段红,李源,张珊红等.川芎嗪对缺血再灌注大鼠心肌细胞凋亡的影响.中华心血管病杂志,1999,27:294.
[21]余乐涵,赵小曼,李华等.川芎嗪对缺血再灌注后心肌细胞凋亡的影响. 江西医学院学报,2006,46:27-29.
[22]陆一敏,万福生,唐三保.川芎嗪对儿茶酚胺诱导大鼠心肌损伤时Bcl-2和Fas蛋白表达的影响.中国临床药理学与治疗学,2004,9:197-200.
[23]陈江斌,唐其柱,孙小梅,等.川芎嗪对复氧后损伤心肌细胞的影响.中国现代应用药学杂志,2001,18:190-191.
[24]陈江斌,江洪,孙小梅等.缺氧-复氧对心室肌细胞的损伤及川芎嗪的保护作用.中国临床药理学与治疗学,2000,5:18-20.
[25]石刚刚,尹俊,陈少如.当归和丹参对家兔心肌缺血再灌注损伤的保护作用.中国临床药学杂志,1999,8(2):104-106.
[26]徐长庆,王孝铭.丹参酮ΠA 对豚鼠单个心室肌细胞跨膜电位及L-型钙电流的影响.中国病理生理杂志,1997,13(1):43-44.
[27]李玉梅,陈旭华.丹参对缺血心肌细胞L型钙电流的影响.安徽中医学院学报,2003,22(4):29-30.
[28]赵桂峰,张红霞,范英昌.丹酚酸B对大鼠心肌缺血再灌注损伤的保护作用.辽宁中医学院学报,2004,6(1):55-56.
[29]赵立波,佟力,赵洪序等.人参总皂甙对心肌缺血再灌注损伤的保护作用实验研究.中华胸心血管外科杂志,1994,10(4):353-354.
[30]张杰民,赵立波,赵洪序,等.人参总皂甙对心肌缺血和再灌注损伤的保护作用及浓度效应关系的实验研究.白求恩医科大学学报,1998,24(3):254-256.
[31]侯明晓,敖定椿.人参总皂甙抗心肌缺血再灌注损伤的作用机制.中国胸心血管外科临床杂志,2000,7(4):256-259.
[32]袁茂昆,赵洪序,宋翔翎等.人参二醇组皂甙对缺血心肌再灌注损伤的保护作用及其浓度 效应关系.白求恩医科大学学报,1997,23(5):492-493.
[33]陈立波,崔东哲,刘玉梅等.人参二醇组皂甙对家兔缺血再灌注损伤心肌线粒体的影响.中国中药科技报,2003,10(3):152-153.
[34]田健明,郑淑秋,郭伟芳等.人参皂甙Rg2对大鼠心肌缺血再灌注损伤诱发心肌细胞凋亡的保护作用.中国药理学通报,2004,20(4):480.
[35]曾和松,刘正湘.人参皂甙Re对急性缺血再灌注心肌细胞凋亡及fas基因表达的影响.华中科技大学学报,2004,33(3):286-288.
[36]刘晓春,刘正湘,施静.人参对缺血再灌注大鼠心肌细胞凋亡影响的实验研究 中国组织化学与细胞化学杂志,2000;9:261.
[37]刘正湘,刘晓春,李志刚.人参皂甙Re抗大鼠急性缺血再灌注心肌细胞凋亡及相关基因蛋白表达.中华急诊医学杂志,2003;(12):158.
[38]殷惠军,张颖,蒋跃绒等.西洋参叶总皂苷对急性心肌梗死大鼠心肌细胞凋及凋亡相关基因表达的影响.中国中西医结合杂志,2005,25(3):232-235.
[39]金铭,曲绍春,于小凤等.洋参二醇皂甙注射液对大鼠心肌缺血再灌注损伤的影响 天津中医药,2006;23(2):154-156.
[40]刘启功,王琳,陆再英,等.葛根素抗心肌缺血及其机理的实验研究.临床心血管病杂志,1998,14(5):292-295.
[41]沈炳权,蔡兆斌,徐群红.葛根素对家兔心肌缺血-再灌注损伤的保护作用[].中国中西医结合急救杂志,2004,11(6):261.
[42]卢金萍,任江华,姚述远.葛根素对心肌缺血再灌注损伤的保护作用[].中国现代应用药学杂志,2004,21(4):268.
[43]刘薇,王亚利,张式暖.葛根素对慢性缺氧心肌保护作用的试验研究[].山东医药,2006,46(5):15.
[44]高翔,高全,李涛.葛根素预处理保护心肌缺血再灌注损伤的机制[].贵阳医学院院报,2007,32(1):37.
[45]常志文,刘琦.缺血再灌注心肌细胞凋亡及药物干预.中国新药杂志,2000,9(1):28-30.
[46]顾国嵘,黄培志,葛均波,等.缺血及三七总皂苷预处理对心肌缺血-再灌流损伤的保护作用.中华急诊医学杂志,2005,14(4):307.
[47]陈锋,王成天,王炎林,等.三七总皂苷及单体Rb1对大鼠心肌缺血再灌注基因表达谱影响的探讨.中国药物与临床,2003,3(3):229.
[48]陈彦静,李建东,黄启福.三七总皂苷对hng Ⅱ诱导心肌细胞凋亡的影响.中国中药杂志 2005,30(10):778.
[49]闫彦芳张壮,孙塑伦,等.三七总皂苷及其主要成分对血管内皮细胞缺氧损伤的保护作用.中国实验方剂学杂志,202,8(1):34.
[50]唐旭东,姜建青,刘宝玉,等.三七总皂苷对心肌缺血再灌注损伤保护作用的分子机制.安徽中医学院学报,2003,22(1):34.
[51]汪坚敏,王俏,朱健.三七总皂苷对冠心病不稳定性心绞痛患者内皮功能的影响.临床中老年保健,2002,5(3):183.
[52]孙小梅,姚琰,纪三姣,等.三七总皂苷对冠心病病人血浆内颗粒膜蛋白和血小板聚集的影响.数理医药学杂志,2001,14(1):26.
[53]王阶,许军,衷敬柏,等.三七总苷对高黏血症患者血小板活化分子表达和血小板聚集的影响.中国中西医结合杂志,2004,24(4):312.
[54]郑曙云,徐建国,赵振中.参附注射液对大鼠心肌缺血再灌注损伤的影响[J].中国中西医结合杂志,2004,24(6):541--544
[55]郭莲怡,刘仁光.参麦注射液对兔心肌缺血再灌注内皮功能的影响[J].临床心血管病杂志,2003,19(9):545-547
[56]金露,符德玉,罗海明,等.黄芪注射液对大鼠离体心脏缺血再灌注损伤的保护作用[J].中西医结合心脑血管病杂志,2006,4(4):311--312
[57]王硕仁,刘红旭,赵冬等.北京地区1242例急性心肌梗死患者住院治疗状况调查.第八次全国中西医结合心血管学术会议,2007,229-234.
[1]Lefer DJ,Flynn DM,Buda AJ.Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion[J].Am J Physiol.1996,270:H88-H96
[2]孙桂波,徐惠波,温富春,等.龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用.中国药理学通报,2006,22(9):1092-1095.
[3]赵江民,倪炯,李铭.心肌梗死早期病理改变的实验研究[J].同济大学学报(医学版),2005,26(6):12-15.
[4]张英杰,刘仁光.大鼠急性心肌缺血早期心电图QRS波群和ST段改变.中国心血管病研究杂志,2005,3:456-458.
[5]崔现军,疏欣阳.急性心肌梗死中医治疗的两点策略.医学与哲学,2007,28(5):73-74.
[6]王硕仁,刘红旭,赵冬等.北京地区1242例急性心肌梗死患者住院治疗状况调查.第八次全国中西医结合心血管学术会议,2007,229-234.
[7]邢桂菊.龙牙楤木的药理作用.中国药师,2006,9(2):181-182.
[8]周仲楚,孙晓波,刘威,等.龙牙楤木总甙的抗炎作用.中国药理学与毒理学杂志,1991,5(1):31-33.
[9]葛敬岩,郭春尧,赵春燕,等.龙牙葱木皂苷对大鼠血流动力学的影响.白求恩医科大学学 报.2001,27(6):601-602.
[10]孙桂波,徐惠波,温富春,等.龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用.中国药理学通报,2006,22(9):1092-1095.
[11]吴克复.细胞通讯与疾病.科学出版社,2006,p24.
[12]GengJG,MooreK,ArthurEJ,etal.Neutrophil recognition requires a Ca2+-induced comformational change in the lectin domain of GMP-140[J].J Biol Chem,1991,266(33):22313-22318
[13]敖强国,张丽萍,李健,等.氯吡格雷对高龄冠心病患者血小板功能的影响.中华保健医学杂志,2008,10(1):21-23
[14]依仁科,邹玲,宋耀锋,等.氯吡格雷对急性冠脉综合征的抗感染作用观察.中国医药导报,2007,4(36):92-93
[15]李芳,余素琴,杜艳华,等.氯吡格雷在急性冠状动脉综合征中的抗炎作用.临床心血管病杂志,2006,22(12):716-718
[16]刘芳,沈小梅.老年急性冠状动脉综合征患者血小板P选择素、血管性血友病因子的变化及氯吡格雷干预的临床研究.中国心血管杂志,2007,12(5):337-340
[17]Komstsu S,Panes J,Russell JM,et al.Effect of chronic arterialhypertension on constitutive and induced VCAM- 1 expression invivo.Hypertension,1997,29:683-689
[18]Scalbert EP,Guardiola-Lemaitre B,Delagrange P.Melatonin and regulation of the cardiovascular system.Therapie,1998,53:459-465.
[19]Zweier JL.Measurement of superoxide-derived free radicals in the reperfused heart:Evidence for a free radical mechanism of reperfusion injury.J Biol Chem,1988,263:1353-1357.
[20]Hearse D J,Humphrey SM,Chain EB.Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart:a study of myocardial enzyme release.Mol Cell Cardiol,1973,5:395-407.
[21]Komstsu S,Panes J,Russell JM,et al.Effect of chronic arterialhypertension on constitutive and induced ICAM- 1 expression invivo.Hypertension,1997,29:683-689
[22]Fliss H,Gattinger D.Apoptosis in ischemic and reperfused rat myocardium.Cite Res,1996,9:949
[23]Niessen HW,Krijnen PA,Visser CA et al.Intercellular adhesion molecule -1 in the heart.Ann N Y Acad Sci,2002,97(3):573
[24]Inculano M,Squadrito F,Altavilla D et al.Antibodies against inter-cellular adhesion molecule-1 protect against myocardial ischemia reperfusion injury in rat.Eur J Pharmacol,1994,264(2):143
[25]Wang NP,Bufkin BL,Nakamura M et al.Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis.Ann Thorac Surg,1999,67(6):1689
[26]Curtis MJ,Walker MJ.Quantification of arrhythmias using scoring systems:an examination of seven scores in an in vivo model of regional myocardial ischemia[J].Cardiovasc Res,1988,22(9):656-665.
[27]富路,梁淑华.急性心肌缺血再灌注期心室易颤期测定的意义[J].中国急救医学,1995,2(1):20
[28]Anastasiou-Nana MI,Tsagalou EP,Charitos C.Effects of transient myocardial ischemia on the ventricular defibrillation threshold[J].Pacing Clin Electrophysiol,2005,28(2):97-101.
[29]邓汉武,李元建,沈乃,等.辽东楤木总苷对大鼠实验性心肌缺血的保护作用[J].中国药理学与毒理学杂志,1988,2(1):20
[30]Danese S,Sans M,Fiocchi C.The CD40/CD40L costimulatory pathway in inflammatory bowel disease.Gut,2004,53(7):1035-1043.
[31]Heeschen C,Dimmeler S,Hamm CW,et al.Soluble CD40 ligand in acute coronary syndromes.N Engl J Med,2003,348:1104-1111
[32]Apple FS,Smith SW,Pearce LA,.et al.Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.Clin Chem.2009,55(1):93-100.
[33]Dominguez-Rodriguez A,Abreu-Gonzalez P,Garcia-Gonzalez MJ,et al.Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome.Soluble CD40 ligand and diurnal variation.Thromb Res.2009,123(4):617-21
[34]Khandoga A,Hanschen M,Kessler JS,et al.CD4~+ T eel Is contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets.Hepatology,2006,43(2):306-315.
[35]Moore TM,Shirah WB,Khimenko PL,et al.Involvement of CD40-CD40L signaling in postischemic lung injury.Am J Physiol Lung Cell Mol Physiol,2002,283(6):1255-1262.
[36]Ke B,Shen XD,Gao F,et al.The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses.Transplantation,2005,79(9):1078-1083.
[37]Ishikawa M,Vowinkel T,Stokes KY,et al.CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion.Circulation,2005,111(13):1690-1696.
[38]Henn V,Slupsky JR,Grafe M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.Nature,1998,391:591-594.
[39]Henn V,Steinbach S,Buchner K,et al.The inflammatory action of CD40 ligand(CD154)expressed on activated human platelets is temporally limited by coexpressed CD40.Blood,2001,98(4):1047-1054.
[40]Subrata Chakrabarti,Sonia Varghese,Olga Vitseva,et al.CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates.Arterioscler Thromb Vase Biol.2005,25(11):2428-2434.
[41]Nannizzi-Alaimo L,Alves VL,Phillips DR.Inhibitory effects of glycoprotein 11 b/ Ilia antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.Circulation.2003;107(8):1123-1128.
[42]Urbich C,Dernbach E,Aicher A,et al.CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species.Circulation.2002;106:981-986.
[43]Aymong ED,Curtis MJ,Youssef M,et al.Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting.Circulation 2002;105:2981-2985.
[44]Heitzer T,Ollmann I,KokeK,et al.Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.Circulation 2003;108:536-541.
[45]Y-J Yang,J-L Zhao,S-J You,et al.Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.Heart,2006;92:1131-1137.
[46]彭祖林,周启林.急性冠脉综合征的抗血小板聚集治疗对血浆CD40L的影响.南华大学学报·医学版.2006,34(3):427-428
[47]Azar RR,Kassab R,Zoghbi A,et al.Effects of clopidogrel on soluble CD40 ligand and on high-sensitivityC-reactive protein in patients with stable coronary artery diseas,Am Heart J.2006,151(2):521.e1-521.e4
[48]Yip HK,Chang LT,Sun CK,et al.Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting,Am J Cardiol.2006,15;97(2):192-194.
[49]刘恒亮,陈奇,刘灵芝,等.β受体阻滞剂对家兔心肌缺血再灌注后纤溶活性及血管活性物质含量的影响.基础医学与临床2004,24(5):537-540
[50]赵向民,汪家瑞,叶丹,等.美托洛尔对缺血再灌注心肌的保护作用及其机制探讨.心肺血管病杂志,2001,20(3):179-180
[2]王桂云,张淑芹,董琦.龙牙楤木嫩芽生品对小鼠脑及肝SOD及MDA的影响[J].中国林副特产,2003,(1):10
[3]师海波,孙英莲,刘威,等.龙牙楤木总苷对小鼠B型单胺氧化酶及蛋白质合成的影响[J].中药药理与临床,1999,15(6):20-21
[4]葛敬岩,赵春燕.龙牙楤木皂苷对实验性心力衰竭大鼠心功能的影响[J].吉林大学学报,2005,31(2):243-245
[5]葛敬岩,郭春尧,赵春燕,等.龙牙楤木皂苷对大鼠血流动力学的影响[J].白求恩医科大学学报,2001,27(6):601-602
[6]姜永涛,徐绥绪.龙牙楤木化学组成及药理活性[J].沈阳药学院学报,1990,7(4):290
[7]邓汉武,李元建,沈乃,等.辽东楤木总苷对大鼠实验性心肌缺血的保护作用[J].中国药理学与毒理学杂志,1988,2(1):20
[8]孙桂波,徐惠波,温富春,等。龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用[J]国药理学通报,2006,22(9):1092-1095
[9]Tomatsu M,Ohnishi Kameyama M,Shibamoto N.Aralin,a new cytotoxic protein from Aralia elata,inducing apoptosis in human cancer cells[J].Cancer Lett,2003,199(1):19-25.
[10]Tomatsu M,Mujin T,Shibamoto N,Tashiro F,Ikuta A.Production of aralin,a selective cytotoxic lectin against human transformed cells,in callus culture of Aralia elata.[J]Planta Med.2004,70(5):469-71
[11]吴勃岩,王晶,宋春燕.龙牙楤木总皂苷对荷瘤鼠TNF-α的诱生作用[J].中医药学报,2003,31(6):52-53
[12]吴勃岩,祝司霞,王晶.龙牙楤木总皂苷对荷瘤鼠突变型p53表达的影响[J].中医药学报,2005,33(1):38-39
[13]吴勃岩,郭艳莹,毕克滨,等.龙牙楤木总皂苷对荷瘤鼠IL-2含量及其细胞凋亡的影响[J].中医药信息,2005,22(6):58-59
[14]吴勃岩,张韵娴.龙牙楤木总苷的遗传毒性研究[J].中医药学报,1999,(6):47
[15]吴勃岩,韩玉英.龙牙楤木总苷对HepA小鼠肿瘤组织蛋白的表述及M 吞噬功能的影响[J].哈尔滨医科大学学报,2002,(4):45-46
[16]吴勃岩,文杰,张韵娴。龙牙楤木叶总皂苷抗诱变性研究[J].中医药信息,2000,(4):74
[17]季宇彬,李文举,谷春山,等.复方海藻多糖合剂抗癌作用的试验研究[J]. 中国海洋药物,1994,13(3):20-24
[18]西田圭志.辽东楤木中的皂昔对肝炎的效果[J].国外医学·中医中药分册,1990,12(4):63
[19]Saito S,Ebashi J,Sumita S.Comparison of cytoprotective effects of saponins isolated from leaves of Aralia elata Seem.(Araliaceae)with synthesized bisdesmosides of oleanoic acid and hederagenin on carbon tetrachloride-induced hepatic injury[J].Chem Pharm Bull (Tokyo),1993,41(8):1395-401.
[20]杜施霖,迟宝荣.龙牙楤木皂苷对大鼠酒精性肝病的防治作用[J].吉林大学学报(医学版),2005,31(1):64-67
[21]李凡,田同春,石艳春.龙牙楤木总皂苷抗病毒作用研究[J].中国中药杂志,1994,19(9):562-564
[22]孙晓波,周重楚,刘威,等.龙牙楤木总苷的强壮作用[J].中草药,1991,21(2):78
[23]Chung YS,Choi YH,Lee SJ.Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo[J].Ethnopharmacol.2005,3,101(1-3):49-54.
[24]Suh SJ,Jin UH,Kim KW.Triterpenoid saponin,oleanolic acid 3-0-beta-d-glucopyranosyl(1-->3)-alpha-1-rhamnopyranosyl(1-->2)-al pha-1-arabinopyranoside(OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-kappaB in raw 264.7cells,Arch Biochem Biophys.2007,467(2):227-233
[25]周重楚,师海波,李文亭,等.长白木醇提取物的抗炎作用[J].中草药,1991,22(3):114
[26]高勃,张鹏.楤木总苷的中枢抑制作用[J].第四军医大学学报,1988,9(1):55
[27]江苏新医学院.中药大辞典[M].上海:上海人民出版社,1997,2583.
[28]周重楚,师海波,李文亭,等.龙牙楤木总苷的抗缺氧作用[J].中草药,1991,22(3):114
[29]黄立成,姜平.楤木总苷对缺氧耐力的影响[J].西北药学杂志,1988,3(1):13-16
[30]姜永涛,徐绥绪.龙牙楤木化学组成及药理活性[J].沈阳药学院学报,1990,7(4):290
[31]周重楚,孙晓波,高洪波,等.龙牙楤木总苷对变态反应的影响抗炎作用研究[J].中国药理学与毒理学杂志,1991,5(1):34
[32]Kim,Ok kyung,Antihyperglycemic constituent of Aelata rootbark (2) isolation and action of the constituent[J].Aengyak Hakhoechi,1993,24(3):219
[33]Yoshikawa M,Murakami T,Harada E.Bioactive saponins and glycosides.VII.On the hypoglycemic principles from the root cortex of Aralia elata Seem.:structure related hypoglycemic activity of oleanolic acid oligoglycoside[J].Chem Pharm Bull(Tokyo).1996,44(10):1923-1927
[34]Yoshikawa M,Yoshizumi S,Ueno T.Medicinal foodstuffs.I.Hypoglycemic constituents from a garnish foodstuff "taranome," the young shoot of Aralia elata SEEM.:elatosides G,H,I,J,and K[J].Chem Pharm Bull(Tokyo),1995,43(11):1878-1882.
[1]Derek M,Yellon DS.Myocardial Reperfusion Injury.N Eng J Med,2007,357:1121-1135.
[2]Ferdinandy P,Schulz R,Baxter GF.Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury,preconditioning and postcondition- ing.Phamacol Rev,2007,59:418-458
[3]Scalbert EP,Guardiola-Lemaitre B,Delagrange P.Melatonin and regulation of the cardiovascular system.Therapie,1998,53:459-465.
[4]Zweier JL.Measurement of superoxide-derived free radicals in the reperfused heart:Evidence for a free radical mechanism of reperfusion injury.J Biol Chem,1988,263:1353-1357.
[5]Hearse D J,Humphrey SM,Chain EB.Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart:a study of myocardial enzyme release.Mol Cell Cardiol,1973,5:395-407.
[6]Karlsson J.Introduction to Nutraology and Radical Formation.Human Kinetics Press,1997,1-143
[7]Shinohara R,Mano T,Nagasaka A,et al.Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status.J Endocrinol,2000,164(1):97-192
[8]Zhao ZQ.Oxidative stress-elicited myocardial apoptesis during reperfusien.Curt Opin Pharmacol,2004,4:159-165.
[9]Romson JL.Reduction of the exent of myocardial ischemic injury by neutrophil depletion in the dog.Circulation,1983,67(5):1016-1023
[10]Granger DN.Superoxide radicals infelin inteseinal ischemia.Astroenterology,1981,81(1):22-29
[11]朱妙章,钱学贤.心肌损伤和缺血/再灌注损伤.北京:人民军医出版社,2003.
[12]贾新未.氧化应激与血管内皮素功能异常.国际心血管病杂志,2006,33(2):20-21
[13]袁红洁.氧自由基对血管内皮细胞周期及其凋亡水平的影响.南京医科大学学报,1999,19(5):396-397
[14]戴瑞鸿,李勇,范维琥,等.保护内皮细胞功能在防治心血管疾病中的重要性.国际心血管杂志,2000,2(4):328
[15]Reiter RJ,Tan DX,Qi,et al.Pharmacology and physiology of melatonin in the recduction of oxidative stress in vivo.Biol Sigals Recept,2000,9(3-4):160-171
[16]Anisimov VN,Zavarzain NY.Melatonin increases both life span and tumor incidence in female CBA mice.J Gernontol A Biol Sci Ned Sci,2001,56(7):B311-323
[17]Bushehri N,Jarrell ST,Lieberman S,et al.Oral reduced B-nicotinamide ademne dinucleotide(NADn) affects blood pressure,lipid peroxidation,and lipid profile in hypertensive rats(SHR).Geriatr Nephrol Urol,1998,8(2):95-100
[18]Pamplona R,Portero-Otin M,Ruiz C,et al.Double bond content of phospholipids and lipid peroxidation egatively correlate with maximum longevity in the heart of mammals.Geriatr Nephrol Urol,2000,112(3):169-183
[19]Cifuentes ME,Pagano PJ.Targeting reactive oxygen species in hypertension.Curt Opin Nephrol Hypertens,2006,15:179-186.
[20]Das S,Engelman RM,Maulik N,et al.Angiotensin preconditioning of the heart:evidence for redox signaling.Cell Biochem Biophys,2006,44:103-131.
[21]Halestrap AP,Clarke S J,Khaliulin L The role of mitochoudria in protection of the heart by preconditioning.Biochim Biophys Acta,2007,1767:1007-1031.
[22]Gozal Y,Drenger B.Myocardial ischemic preconditioning decreases postischemie oxygen free radical production.Anesthesiology,2003,98:281-282.
[1]RossR.Atherosclerosisaninflammatory disease[J].NEngl JMed,1999,340:115
[2]梅家俊,陈振发.超微病理学基础临床病理学进展[M].武汉:湖北中医学院,2001:95-97;88
[3]邓耀祖,曲伸.医学分子细胞生物学[M].北京:科学出版社,2002:494
[4]莫简.医用自由基生物学导论[M].北京:人民卫生出版社,1989:93-164
[5]龚非力.医学免疫学[M].北京:科学出版社,2000:269,63
[6]Morishima I,Sone T,Okumura K,etal.Angiographic no-reflow phenomenon:a as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J].J Am Corl Cardiol,2000,36:1202
[7]Kloner RA,Rude RE,Carlson N,etal.Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary occlusion:Which comes first?[J].Circulation,1980,62:945
[8]Moncada S,Higgs A.The L-arginine-nitricoxide pathway[J].New Eng J Med,1993,329:2002
[9]Li C,Browder W,Kao R.Early activation of transcription factor NF-kB during lachemia in perfused rat heart[J].Am J physical,1999,276:H543
[10]李淑慧,李晓辉.三七总皂甙抗炎作用机制的实验研究[J].中草药,2000,31(9):676
[11]汪德清,沈文梅,田亚平,等.黄芪有效成分对氧自由基清除作用的ESR研究[J].生物化学与生物物理进展,1996,23(3):260
[12]刘军,匡培根,李斌,等.丹参对大鼠脑缺血再灌注损伤保护机制的实验研究[J].中国神经免疫学和神经病学杂志,1998,5(2):77-82
[13]钟瑜,张焱,杨国汗.川芎嗪对脑缺血再灌注损伤后细胞间粘附作用的影响[J].中西医结合心脑血管杂志,2003,1(5):257,293
[14]倪军,王军,张三林,等.莪红注射液对大鼠心肌缺血再灌注保护作用的研究[J].中西医结合心脑血管杂志,2003,1(10):586-587
[15]倪军,张三林,卫世强,等.莪红注射液对不稳定心绞痛病人血小板颗粒膜蛋白、C反应蛋白的影响[J].中西医结合心脑血管杂志,2003,1(6):326-327[16]沈强,刘亚敏,张赐安.麝香、冰片对全脑缺血再灌注大鼠脑微血管内皮细胞ICAM-1表达的影响[J].中西医结合心脑血管杂志,2003,1(3):136-137
[1]吴克复.细胞通讯与疾病.科学出版社,2006,p24.
[2]孙忠人,张丽娟,赵宇辉,等.针刺预处理对心肌缺血再灌注损伤大鼠c-fos蛋白的影响.中医药信息,2008,25(4):74-75
[3]孙忠人,王一茗.逆灸对心肌缺血再灌注损伤大鼠HSP70的影响.中华中医药学刊.2008,26(7):1382-1383
[4]贺运河,古继红,陈光贤等.益气活血法对大鼠心肌缺血再灌注损伤保护作用的实验研究.中西医结合心脑血管病杂志,2007,5(8):707-708.
[5]戴小华,韩宁林,周宜轩等.益气活血法对心肌缺血再灌注损伤大鼠肿瘤坏死因子α及丙二醛含量的影响.安徽中医学院学报,2003,22(4):39-41.
[6]陈利平,易军.益心汤对心肌缺血再灌注损伤保护作用的研究.解放军医学杂志2003,28(5):447-448.
[7]杨跃进.通心络、卡维地洛及缬沙坦等药物对兔急性心肌梗死晚期再灌注心肌超微结构的影响.络病与心脑血管疾病相关性治疗研究进展学术研讨会论文集.中华医学会杂志社,2004,12:43.
[8]刘艳,赵丹洋,赵明奇,等.通心络改善缺血心肌供血的NO机制研究.络病与心脑血管疾病相关性治疗研究进展学术研讨会论文集.中华医学会杂志社,2004.12:97.
[9]王晓霞,陈志强,刘丽华.参麦注射液对大鼠心肌缺血再灌注损伤的保护效应及其与热休克蛋白的关系,微循环学杂志,2002,12(4):36-37.
[10]郭莲怡,刘仁光.参麦注射液对兔心肌缺血再灌注内皮功能的影响.临床心血管病杂志,2003,19(9):545-547.
[11]郭莲怡,刘仁光.参附注射液对兔心肌缺血再灌注损伤内皮功能的影响.中国中医急症,2003,12(4):349-350.
[12]郑曙云,徐建国,赵振中.参附注射液对大鼠心肌缺血再灌注损伤的影响.中国中西医结合杂志,2004,24(6):541-548.
[13]申捷,许鹏程.参附注射液对缺血再灌注心肌损伤的保护作用.中国临床医学,2006,13(3):344-346.
[14]陈潮,卢伟花.冠脉通瘀汤对心肌缺血再灌注保护作用的研究.中国中医急症,2008,17(7):899-907
[15]侯泽,康文英,沃兴德等.血府逐瘀汤对乳鼠心肌细胞缺血再灌注损伤的影响.中国药物与临床,2006,6(8):590-593.
[16]马骏,石月萍,赵建宇.温阳通脉方预处理对心肌缺血再灌注大鼠MDA 及SOD的影响.中西医结合心脑血管病杂志,2008,6(6):664-665.
[17]王万铁,徐正祄,林丽娜.川芎嗪对实验性缺血-再灌注损伤心肌能量代谢的干预.中国急救医学,2003,23(3):129-130.
[18]王万铁,许涛,徐正祄.川芎嗪对缺血 再灌注损伤兔心肌线粒体结构及功能的影响.基础医学与临床,2004,24(3):295-298.
[19]徐持华,张卫东.川芎嗪对大鼠缺血再灌注心肌预适应性保护与一氧化氮的关系.中国临床康复,2006;10:74-76.
[20]段红,李源,张珊红等.川芎嗪对缺血再灌注大鼠心肌细胞凋亡的影响.中华心血管病杂志,1999,27:294.
[21]余乐涵,赵小曼,李华等.川芎嗪对缺血再灌注后心肌细胞凋亡的影响. 江西医学院学报,2006,46:27-29.
[22]陆一敏,万福生,唐三保.川芎嗪对儿茶酚胺诱导大鼠心肌损伤时Bcl-2和Fas蛋白表达的影响.中国临床药理学与治疗学,2004,9:197-200.
[23]陈江斌,唐其柱,孙小梅,等.川芎嗪对复氧后损伤心肌细胞的影响.中国现代应用药学杂志,2001,18:190-191.
[24]陈江斌,江洪,孙小梅等.缺氧-复氧对心室肌细胞的损伤及川芎嗪的保护作用.中国临床药理学与治疗学,2000,5:18-20.
[25]石刚刚,尹俊,陈少如.当归和丹参对家兔心肌缺血再灌注损伤的保护作用.中国临床药学杂志,1999,8(2):104-106.
[26]徐长庆,王孝铭.丹参酮ΠA 对豚鼠单个心室肌细胞跨膜电位及L-型钙电流的影响.中国病理生理杂志,1997,13(1):43-44.
[27]李玉梅,陈旭华.丹参对缺血心肌细胞L型钙电流的影响.安徽中医学院学报,2003,22(4):29-30.
[28]赵桂峰,张红霞,范英昌.丹酚酸B对大鼠心肌缺血再灌注损伤的保护作用.辽宁中医学院学报,2004,6(1):55-56.
[29]赵立波,佟力,赵洪序等.人参总皂甙对心肌缺血再灌注损伤的保护作用实验研究.中华胸心血管外科杂志,1994,10(4):353-354.
[30]张杰民,赵立波,赵洪序,等.人参总皂甙对心肌缺血和再灌注损伤的保护作用及浓度效应关系的实验研究.白求恩医科大学学报,1998,24(3):254-256.
[31]侯明晓,敖定椿.人参总皂甙抗心肌缺血再灌注损伤的作用机制.中国胸心血管外科临床杂志,2000,7(4):256-259.
[32]袁茂昆,赵洪序,宋翔翎等.人参二醇组皂甙对缺血心肌再灌注损伤的保护作用及其浓度 效应关系.白求恩医科大学学报,1997,23(5):492-493.
[33]陈立波,崔东哲,刘玉梅等.人参二醇组皂甙对家兔缺血再灌注损伤心肌线粒体的影响.中国中药科技报,2003,10(3):152-153.
[34]田健明,郑淑秋,郭伟芳等.人参皂甙Rg2对大鼠心肌缺血再灌注损伤诱发心肌细胞凋亡的保护作用.中国药理学通报,2004,20(4):480.
[35]曾和松,刘正湘.人参皂甙Re对急性缺血再灌注心肌细胞凋亡及fas基因表达的影响.华中科技大学学报,2004,33(3):286-288.
[36]刘晓春,刘正湘,施静.人参对缺血再灌注大鼠心肌细胞凋亡影响的实验研究 中国组织化学与细胞化学杂志,2000;9:261.
[37]刘正湘,刘晓春,李志刚.人参皂甙Re抗大鼠急性缺血再灌注心肌细胞凋亡及相关基因蛋白表达.中华急诊医学杂志,2003;(12):158.
[38]殷惠军,张颖,蒋跃绒等.西洋参叶总皂苷对急性心肌梗死大鼠心肌细胞凋及凋亡相关基因表达的影响.中国中西医结合杂志,2005,25(3):232-235.
[39]金铭,曲绍春,于小凤等.洋参二醇皂甙注射液对大鼠心肌缺血再灌注损伤的影响 天津中医药,2006;23(2):154-156.
[40]刘启功,王琳,陆再英,等.葛根素抗心肌缺血及其机理的实验研究.临床心血管病杂志,1998,14(5):292-295.
[41]沈炳权,蔡兆斌,徐群红.葛根素对家兔心肌缺血-再灌注损伤的保护作用[].中国中西医结合急救杂志,2004,11(6):261.
[42]卢金萍,任江华,姚述远.葛根素对心肌缺血再灌注损伤的保护作用[].中国现代应用药学杂志,2004,21(4):268.
[43]刘薇,王亚利,张式暖.葛根素对慢性缺氧心肌保护作用的试验研究[].山东医药,2006,46(5):15.
[44]高翔,高全,李涛.葛根素预处理保护心肌缺血再灌注损伤的机制[].贵阳医学院院报,2007,32(1):37.
[45]常志文,刘琦.缺血再灌注心肌细胞凋亡及药物干预.中国新药杂志,2000,9(1):28-30.
[46]顾国嵘,黄培志,葛均波,等.缺血及三七总皂苷预处理对心肌缺血-再灌流损伤的保护作用.中华急诊医学杂志,2005,14(4):307.
[47]陈锋,王成天,王炎林,等.三七总皂苷及单体Rb1对大鼠心肌缺血再灌注基因表达谱影响的探讨.中国药物与临床,2003,3(3):229.
[48]陈彦静,李建东,黄启福.三七总皂苷对hng Ⅱ诱导心肌细胞凋亡的影响.中国中药杂志 2005,30(10):778.
[49]闫彦芳张壮,孙塑伦,等.三七总皂苷及其主要成分对血管内皮细胞缺氧损伤的保护作用.中国实验方剂学杂志,202,8(1):34.
[50]唐旭东,姜建青,刘宝玉,等.三七总皂苷对心肌缺血再灌注损伤保护作用的分子机制.安徽中医学院学报,2003,22(1):34.
[51]汪坚敏,王俏,朱健.三七总皂苷对冠心病不稳定性心绞痛患者内皮功能的影响.临床中老年保健,2002,5(3):183.
[52]孙小梅,姚琰,纪三姣,等.三七总皂苷对冠心病病人血浆内颗粒膜蛋白和血小板聚集的影响.数理医药学杂志,2001,14(1):26.
[53]王阶,许军,衷敬柏,等.三七总苷对高黏血症患者血小板活化分子表达和血小板聚集的影响.中国中西医结合杂志,2004,24(4):312.
[54]郑曙云,徐建国,赵振中.参附注射液对大鼠心肌缺血再灌注损伤的影响[J].中国中西医结合杂志,2004,24(6):541--544
[55]郭莲怡,刘仁光.参麦注射液对兔心肌缺血再灌注内皮功能的影响[J].临床心血管病杂志,2003,19(9):545-547
[56]金露,符德玉,罗海明,等.黄芪注射液对大鼠离体心脏缺血再灌注损伤的保护作用[J].中西医结合心脑血管病杂志,2006,4(4):311--312
[57]王硕仁,刘红旭,赵冬等.北京地区1242例急性心肌梗死患者住院治疗状况调查.第八次全国中西医结合心血管学术会议,2007,229-234.
[1]Lefer DJ,Flynn DM,Buda AJ.Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion[J].Am J Physiol.1996,270:H88-H96
[2]孙桂波,徐惠波,温富春,等.龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用.中国药理学通报,2006,22(9):1092-1095.
[3]赵江民,倪炯,李铭.心肌梗死早期病理改变的实验研究[J].同济大学学报(医学版),2005,26(6):12-15.
[4]张英杰,刘仁光.大鼠急性心肌缺血早期心电图QRS波群和ST段改变.中国心血管病研究杂志,2005,3:456-458.
[5]崔现军,疏欣阳.急性心肌梗死中医治疗的两点策略.医学与哲学,2007,28(5):73-74.
[6]王硕仁,刘红旭,赵冬等.北京地区1242例急性心肌梗死患者住院治疗状况调查.第八次全国中西医结合心血管学术会议,2007,229-234.
[7]邢桂菊.龙牙楤木的药理作用.中国药师,2006,9(2):181-182.
[8]周仲楚,孙晓波,刘威,等.龙牙楤木总甙的抗炎作用.中国药理学与毒理学杂志,1991,5(1):31-33.
[9]葛敬岩,郭春尧,赵春燕,等.龙牙葱木皂苷对大鼠血流动力学的影响.白求恩医科大学学 报.2001,27(6):601-602.
[10]孙桂波,徐惠波,温富春,等.龙牙楤木总皂苷对缺氧/再给氧心肌细胞损伤的保护作用.中国药理学通报,2006,22(9):1092-1095.
[11]吴克复.细胞通讯与疾病.科学出版社,2006,p24.
[12]GengJG,MooreK,ArthurEJ,etal.Neutrophil recognition requires a Ca2+-induced comformational change in the lectin domain of GMP-140[J].J Biol Chem,1991,266(33):22313-22318
[13]敖强国,张丽萍,李健,等.氯吡格雷对高龄冠心病患者血小板功能的影响.中华保健医学杂志,2008,10(1):21-23
[14]依仁科,邹玲,宋耀锋,等.氯吡格雷对急性冠脉综合征的抗感染作用观察.中国医药导报,2007,4(36):92-93
[15]李芳,余素琴,杜艳华,等.氯吡格雷在急性冠状动脉综合征中的抗炎作用.临床心血管病杂志,2006,22(12):716-718
[16]刘芳,沈小梅.老年急性冠状动脉综合征患者血小板P选择素、血管性血友病因子的变化及氯吡格雷干预的临床研究.中国心血管杂志,2007,12(5):337-340
[17]Komstsu S,Panes J,Russell JM,et al.Effect of chronic arterialhypertension on constitutive and induced VCAM- 1 expression invivo.Hypertension,1997,29:683-689
[18]Scalbert EP,Guardiola-Lemaitre B,Delagrange P.Melatonin and regulation of the cardiovascular system.Therapie,1998,53:459-465.
[19]Zweier JL.Measurement of superoxide-derived free radicals in the reperfused heart:Evidence for a free radical mechanism of reperfusion injury.J Biol Chem,1988,263:1353-1357.
[20]Hearse D J,Humphrey SM,Chain EB.Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart:a study of myocardial enzyme release.Mol Cell Cardiol,1973,5:395-407.
[21]Komstsu S,Panes J,Russell JM,et al.Effect of chronic arterialhypertension on constitutive and induced ICAM- 1 expression invivo.Hypertension,1997,29:683-689
[22]Fliss H,Gattinger D.Apoptosis in ischemic and reperfused rat myocardium.Cite Res,1996,9:949
[23]Niessen HW,Krijnen PA,Visser CA et al.Intercellular adhesion molecule -1 in the heart.Ann N Y Acad Sci,2002,97(3):573
[24]Inculano M,Squadrito F,Altavilla D et al.Antibodies against inter-cellular adhesion molecule-1 protect against myocardial ischemia reperfusion injury in rat.Eur J Pharmacol,1994,264(2):143
[25]Wang NP,Bufkin BL,Nakamura M et al.Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis.Ann Thorac Surg,1999,67(6):1689
[26]Curtis MJ,Walker MJ.Quantification of arrhythmias using scoring systems:an examination of seven scores in an in vivo model of regional myocardial ischemia[J].Cardiovasc Res,1988,22(9):656-665.
[27]富路,梁淑华.急性心肌缺血再灌注期心室易颤期测定的意义[J].中国急救医学,1995,2(1):20
[28]Anastasiou-Nana MI,Tsagalou EP,Charitos C.Effects of transient myocardial ischemia on the ventricular defibrillation threshold[J].Pacing Clin Electrophysiol,2005,28(2):97-101.
[29]邓汉武,李元建,沈乃,等.辽东楤木总苷对大鼠实验性心肌缺血的保护作用[J].中国药理学与毒理学杂志,1988,2(1):20
[30]Danese S,Sans M,Fiocchi C.The CD40/CD40L costimulatory pathway in inflammatory bowel disease.Gut,2004,53(7):1035-1043.
[31]Heeschen C,Dimmeler S,Hamm CW,et al.Soluble CD40 ligand in acute coronary syndromes.N Engl J Med,2003,348:1104-1111
[32]Apple FS,Smith SW,Pearce LA,.et al.Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.Clin Chem.2009,55(1):93-100.
[33]Dominguez-Rodriguez A,Abreu-Gonzalez P,Garcia-Gonzalez MJ,et al.Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome.Soluble CD40 ligand and diurnal variation.Thromb Res.2009,123(4):617-21
[34]Khandoga A,Hanschen M,Kessler JS,et al.CD4~+ T eel Is contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets.Hepatology,2006,43(2):306-315.
[35]Moore TM,Shirah WB,Khimenko PL,et al.Involvement of CD40-CD40L signaling in postischemic lung injury.Am J Physiol Lung Cell Mol Physiol,2002,283(6):1255-1262.
[36]Ke B,Shen XD,Gao F,et al.The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses.Transplantation,2005,79(9):1078-1083.
[37]Ishikawa M,Vowinkel T,Stokes KY,et al.CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion.Circulation,2005,111(13):1690-1696.
[38]Henn V,Slupsky JR,Grafe M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.Nature,1998,391:591-594.
[39]Henn V,Steinbach S,Buchner K,et al.The inflammatory action of CD40 ligand(CD154)expressed on activated human platelets is temporally limited by coexpressed CD40.Blood,2001,98(4):1047-1054.
[40]Subrata Chakrabarti,Sonia Varghese,Olga Vitseva,et al.CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates.Arterioscler Thromb Vase Biol.2005,25(11):2428-2434.
[41]Nannizzi-Alaimo L,Alves VL,Phillips DR.Inhibitory effects of glycoprotein 11 b/ Ilia antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.Circulation.2003;107(8):1123-1128.
[42]Urbich C,Dernbach E,Aicher A,et al.CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species.Circulation.2002;106:981-986.
[43]Aymong ED,Curtis MJ,Youssef M,et al.Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting.Circulation 2002;105:2981-2985.
[44]Heitzer T,Ollmann I,KokeK,et al.Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.Circulation 2003;108:536-541.
[45]Y-J Yang,J-L Zhao,S-J You,et al.Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.Heart,2006;92:1131-1137.
[46]彭祖林,周启林.急性冠脉综合征的抗血小板聚集治疗对血浆CD40L的影响.南华大学学报·医学版.2006,34(3):427-428
[47]Azar RR,Kassab R,Zoghbi A,et al.Effects of clopidogrel on soluble CD40 ligand and on high-sensitivityC-reactive protein in patients with stable coronary artery diseas,Am Heart J.2006,151(2):521.e1-521.e4
[48]Yip HK,Chang LT,Sun CK,et al.Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting,Am J Cardiol.2006,15;97(2):192-194.
[49]刘恒亮,陈奇,刘灵芝,等.β受体阻滞剂对家兔心肌缺血再灌注后纤溶活性及血管活性物质含量的影响.基础医学与临床2004,24(5):537-540
[50]赵向民,汪家瑞,叶丹,等.美托洛尔对缺血再灌注心肌的保护作用及其机制探讨.心肺血管病杂志,2001,20(3):179-180